Navigation Links
Genmab Announces 2008 First Quarter Results
Date:5/28/2008

ty from PDL BioPharma at a price of DKK 1.2 billion (USD 240 million at the date of acquisition).

In January, Genmab announced a new pre-clinical product, HuMax-CD32b. The antibody may have therapeutical potential in the treatment of B-cell chronic lymphocytic leukemia, small lymphocytic lymphoma, Burkitt's lymphoma, follicular lymphoma and diffuse large B-cell lymphoma.

We reached the third milestone in the GlaxoSmithKline collaboration in January when the first patient in the Phase III RA program received treatment and we received a payment of DKK 87 million (approx. USD 18 million).

Outlook Genmab is maintaining its financial guidance for the year and continue to project an operating loss of DKK 900 to 1,000 million and a net loss in the range of DKK 800 to 900 million. Revenues for 2008 are expected to be approx. DKK 1.0 billion.

As of December 31, 2007, Genmab had cash, cash equivalents and short-term marketable securities of DKK 3.7 billion. For 2008, we project that our operations together with the DKK 1.2 billion acquisition of the manufacturing facility in Minnesota will lead to a year end cash position of DKK 1.7 to 1.8 billion (approx. USD 360 million to USD 382 million).

Conference Call Genmab will hold a conference call to discuss the first quarter results tomorrow, Thursday, May 29, 2008, at

3:30 pm CEST

2:30 pm BST

9:30 am EDT

The conference call will be held in English.

The dial in numbers are as follows:

+1-877-857-6173 (in the US) and ask for the Genmab conference call

+1-719-325-4792 (outside the US) and ask for the Genmab conference call

To listen to a live webcast of the call please visit

http://www.genmab.com

Relevant slides for the call can be found on http://www.genmab.com prior to the call.

About Genmab A/S Genmab i
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Passing of Genmab A/S Annual General Meeting
2. Genmab A/S - Notice to Convene Annual General Meeting
3. Genmabs 2007 Annual Report
4. Genmab Announces Year End 2007 Financial Results
5. Genmab and PDL BioPharma Close Sale of Antibody Manufacturing Facility
6. Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets
7. Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility
8. Medarex Announces Completion of Sale of Shares in Genmab A/S
9. Genmabs Financial Calendar for 2008
10. Genmab Reaches Milestones in Ofatumumab Collaboration
11. Genmab Announces HuMax-CD32b Pre-Clinical Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... PA (PRWEB) May 22, 2013 Oven ... with the integrated potentiometers or via a PC ... design measuring two and one half inches square can ... a zero voltage switched, low noise solid state relay. ... power isolation for the communication port and sensor input. ...
(Date:5/22/2013)... May 22, 2013 The Conference ... Disruptive Innovations to Advance Clinical Trials conference taking place ... in Boston, MA. , Disruptive thinkers from Novartis, ... more share bold approaches to reduce expensive infrastructure, engage ... innovation needs to be big, or novel, or it ...
(Date:5/22/2013)... NEW ORLEANS , May 22, 2013  Organogenesis ... medicine, presented new data generated in collaboration with a ... health economics consultancy) demonstrating the significant healthcare resource and ... leg ulcers (VLU) place upon the US healthcare system. ... reveal annual costs of up to $15 billion and ...
(Date:5/22/2013)... 22, 2013 Mold remediation could take a ... there is a way to cut down the process' expense. ... latest post the details of a method how to ... Mold could be prevented, My Cleaning Products said. But in ... that a mold remediation must then be promptly implemented as ...
Breaking Biology Technology:New AC Temperature Controller Announced by Oven Industries 2Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4How to Kill Mold While Saving Thousands of Dollars on Mold Remediation Projects Explained by My Cleaning Products 2
... Feb. 8 Biodel Inc. (Nasdaq:,BIOD) today announced that its first ... 14, 2008. Following the,issuance of its financial results, Biodel,s senior management ... provide an,update on the Company,s developments., February 14, 2008 ... Q1 2008 results will be distributed by PR ...
... Bowl MVP,s; 94 NFL First Round Draft Picks; ... ... BASKING RIDGE, N.J., Feb. 8 Millennium,Biotechnologies Inc., wholly-owned subsidiary ... SURGEX(TM) is,currently being administered as the exclusive post workout nutritional,product provided ...
... Feb. 8 Genomic Health,Inc. (Nasdaq: GHDX ) ... Operations Officer, will present at the BIO CEO &,Investor ... at 10:15 a.m. Eastern,Time., To access the live ... Relations section of Genomic Health,s,website at http://investor.genomichealth.com . ...
Cached Biology Technology:Biodel Inc. to Announce First Quarter Fiscal Year 2008 Financial Results on February 14, 2008 2Biodel Inc. to Announce First Quarter Fiscal Year 2008 Financial Results on February 14, 2008 3Tom Shaw's NFL Training Center Chooses SURGEX(TM) as Their Exclusive Post Training Nutritional Regimen 2Tom Shaw's NFL Training Center Chooses SURGEX(TM) as Their Exclusive Post Training Nutritional Regimen 3
(Date:5/23/2013)... In an age when microbial pathogens are growing ... down infection, a team of Wisconsin scientists has synthesized ... the bacteria that cause staph infections. , Writing online ... , a group led by University of Wisconsin-Madison chemistry ... the "quorum sensing" behavior of Staphylococcus aureus , ...
(Date:5/22/2013)... to improve durability in fuel cell powered buses, ... discovered links between electrode degradation processes and bus ... effects of electrode degradation stressors in the operating ... , The findings of the study, led by ... in a long-term study at Burnaby-based Ballard Power ...
(Date:5/22/2013)... 2013)The omega 3 fatty acids in fish oil have ... so that the American Heart Association currently recommends eating ... fatty varieties rich in omega 3s. However, the mechanism ... a new study, scientists led by Jason R. Carter ... by providing evidence that fish oil might specifically counteract ...
Breaking Biology News(10 mins):University of Wisconsin chemists find new compounds to curb staph infection 2Tests lead to doubling of fuel cell life 2Fish oil may help the heart beat mental stress 2
... eight-year study has concluded that increasingly frequent and severe ... some aquatic desert ecosystems into "catastrophic regime change," from ... just published in the journal Freshwater Biology , ... urban water use, and land management may permanently affect ...
... -- A University of California, Riverside assistant professor of ... to study the impact of air-polluting black carbon particles ... three-year grant from the Environmental Protection Agency will also ... Center for Environmental Research and Technology at UC Riverside,s ...
... other individuals from their voices is second nature to ... mammals that live in social groups are also able ... vocal communication is vital for meerkats. They coordinate their ... members of approaching predators, for instance, and thus stick ...
Cached Biology News:Severe drought, other changes can cause permanent ecosystem disruption 2Severe drought, other changes can cause permanent ecosystem disruption 3Fighting pollution to slow climate change 2Meerkats recognize each other from their calls 2
Rat Cardiac Fibroblasts (RCF) (>500,000 cells)...
QCPN...
... mass detection but not structural information ... spectrometer is ideally suited for high ... performance mass analysis. Typical applications ... detection, micro-satellite DNA characterization and polymer ...
Rat Lung Fibroblasts (RLF) (>500,000 cells)...
Biology Products: